| Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. | |
| | |
MedLine Citation:
|
PMID: 22333849 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVE: To evaluate the efficacy and safety of repeated subconjunctival injections of triamcinolone in the treatment of upper-lid retraction with thyroid-associated ophthalmopathy. DESIGN: Interventional controlled retrospective clinical study. PARTICIPANTS: We studied 23 eyes in 15 patients as the nontreatment control group and 35 eyes in 21 patients as the treatment group. METHODS: In the treatment group, triamcinolone acetonide was subconjunctivally injected into each lid as 4 doses of 20 mg at 1-month intervals. After the treatment, the eyes were divided into 2 groups, response and nonresponse, based on the improvement in margin reflex distance. The eyes of the nontreatment group received no medicine. The eyes were examined regularly. RESULTS: The rate of spontaneous improvement in the nontreatment group was 17.4%. The mean rate of effectiveness was 68.6%. The improvement of upper-lid retraction was 2.31 mm (0 to 7mm). The margin reflex distance was significantly smaller at 1 month after the initiation of treatment. Mean lid retraction time before treatment was 4.58 months in the response group versus 9.91 months in the nonresponse group. In the eyes presenting upper-lid retraction up to 6 months before treatment was initiated, the response rate was 83.3%. The response rate was only 36.4% when lid retraction developed more than 6 months before the procedure. The muscle thickness of the levator/superior rectus complex was significantly reduced after treatment in the response group (5.13 ± 0.85 mm at last follow-up vs. 5.69 ± 0.93 mm at baseline). CONCLUSIONS: Repeated subconjunctival injection of triamcinolone is an effective and safe treatment for upper-lid retraction due to thyroid-associated ophthalmopathy. |
| | |
Authors:
|
Dongdong Xu; Yuhua Liu; Haiyan Xu; Hui Li |
Related Documents
:
|
22982909 - Rituximab in treatment of idiopathic glomerulopathy. 23204749 - Limitations of internal distraction devices in mature patients with cleft lip and palat... 23620499 - Ok-432 sclerotherapy for malleolar bursitis of the ankle. 23453189 - Factors related with the time to surgery in waiting-list patients for knee prostheses. 22663909 - Does mismatch of the femoral component aspect ratio influence the range of knee flexion... 23213039 - Long-term clinical outcome of biliary cast syndrome in liver transplantation recipients. 18056489 - Anterior transposition compared with simple decompression for treatment of cubital tunn... 19267159 - Intraoperative ultrasound versus mammographic needle localization for ductal carcinoma ... 6452799 - A pilot study of the effect of the 5-ht-uptake inhibitor, zimelidine, on phobic anxiety. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie Volume: 47 ISSN: 0008-4182 ISO Abbreviation: Can. J. Ophthalmol. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-02-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0045312 Medline TA: Can J Ophthalmol Country: England |
Other Details:
|
Languages: eng Pagination: 34-41 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Inc. |
Affiliation:
|
Eye Research Center, Chinese Academy of Medical Sciences and Department of Ophthalmology, Peking Union Medical College Hospital, Beijing 100730, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year...
Next Document: Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy.